why choose us

300×250 Ad Slot

Research Article: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway

Date Published: 2023-09-06

Abstract:
The study explored improvements in pulmonary inflammation and fibrosis in a bovine type II collagen-induced rheumatoid arthritis-associated interstitial lung disease mouse model after treatment with baricitinib and the possible mechanism of action.

Introduction:
Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects 1% of the general population. RA attacks the joints, causing progressive erosive destruction of cartilage and bone. The most common extra-articular manifestation is pulmonary involvement, which can affect up to 60% of patients with RA during the disease course [1,2,3]. Interstitial lung disease (ILD) is the most common manifestation of lung involvement in RA, and it is also an important cause of excess mortality among RA patient [4, 5]. The…

Read more

300×250 Ad Slot